Achara Chaovavanich

Learn More
BACKGROUND To compare the adverse events after initiation of NVP-based ART among HIV-infected patients who did not receive fluconazole (group A), received fluconazole 400 mg/week (group B), and received fluconazole 200 mg/day (group C). METHODS A retrospective cohort study was conducted among HIV-infected patients who began NVP-based ART between December(More)
  • 1